Grace Therapeutics, Inc. (GRCE)
Operating Income Growth
-44.47%
TTM · Period ending:
GRCE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-44.47%period ending
Latest reported-44.47%period ending
GRCE TTM Operating Income YoY % (-82.82% → -44.47%)
Year-over-year change
High-resolution chart · PNG
GRCE operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -44.4697% | |
| 39.5311% | |
| 32.1085% | |
| 17.9435% | |
| 1.6667% | |
| -24.9098% | |
| 66.7406% | |
| 69.5446% | |
| 73.4896% | |
| 74.8601% | |
| -186.8401% | |
| -194.3182% | |
| -212.6853% | |
| -233.0987% | |
| -20.0492% | |
| -38.6075% | |
| 15.6695% | |
| 28.2958% | |
| 38.1693% | |
| 51.2107% | |
| -2.8213% | |
| -11.9376% | |
| 3.5983% | |
| -0.3028% | |
| 27.814% | |
| 25.608% | |
| -8.2218% | |
| -31.2517% | |
| -69.0245% | |
| -117.8382% | |
| -136.8828% | |
| -151.9006% | |
| -136.3681% | |
| -61.4076% | |
| -30.2984% | |
| -17.4662% | |
| -2.1372% | |
| 4.492% | |
| 22.4308% | |
| 28.939% | |
| 27.0599% | |
| 24.9112% | |
| 9.7128% | |
| -4.3719% | |
| -2.2969% | |
| -26.5946% | |
| -49.1938% | |
| -44.7423% | |
| -47.9296% | |
| -16.993% | |
| 1.6598% | |
| -0.9113% | |
| -12.5136% | |
| -57.0967% | |
| -108.0985% | |
| -127.6545% | |
| -154.2168% | |
| -135.2538% | |
| -97.0303% | |
| -94.2675% | |
| -82.8168% |